TGFB1 and neoplasm: Erythropoiesis (and more generally hematopoiesis as a whole) is highly impaired by the tumor-induced dysregulation of the TGF-β signaling pathway, which not only hampers cell proliferation but also enhances the production of erythrocytes from HSCs and promotes mitophagy [61].